Found: 6
Select item for more details and to access through your institution.
Serum Midkine Correlates with Tumor Progression and Imatinib Response in Gastrointestinal Stromal Tumors.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2011, v. 18, n. 2, p. 559, doi. 10.1245/s10434-010-1191-0
- By:
- Publication type:
- Article
The misoprostol vaginal insert compared with oral misoprostol for labor induction in term pregnancies: a pair-matched case-control study.
- Published in:
- Journal of Perinatal Medicine, 2018, v. 46, n. 3, p. 309, doi. 10.1515/jpm-2017-0049
- By:
- Publication type:
- Article
Serum Midkine is a clinical significant biomarker for colorectal cancer and associated with poor survival.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 6, p. 2010, doi. 10.1002/cam4.2884
- By:
- Publication type:
- Article
Serum midkine as non-invasive biomarker for detection and prognosis of non-small cell lung cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-94272-8
- By:
- Publication type:
- Article
Universal expression of cell adhesion molecule NCAM in neuroblastoma in contrast to L1: implications for different roles in tumor biology of neuroblastoma?
- Published in:
- 2008
- By:
- Publication type:
- journal article
Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients.
- Published in:
- BMC Cancer, 2011, v. 11, n. 1, p. 189, doi. 10.1186/1471-2407-11-189
- By:
- Publication type:
- Article